Recombinant multi-species CAPN2/Calpain 2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CAPN2/Calpain 2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The calpains, calcium-activated neutral proteases, are nonlysosomal, intracellular cysteine proteases. The mammalian calpains include ubiquitous, stomach-specific, and muscle-specific proteins. The ubiquitous enzymes consist of heterodimers with distinct large, catalytic subunits associated with a common small, regulatory subunit. This gene encodes the large subunit of the ubiquitous enzyme, calpain 2. Multiple heterogeneous transcriptional start sites in the 5' UTR have been reported. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
The Alternative Names of target: CALP80,CANP2,CANPL2,CANPml,CAPN2,Calcium-activated neutral proteinase 2 (CANP 2),Calpain 2,Calpain M-type,Calpain large polypeptide L2,Calpain-2 catalytic subunit,Calpain-2 large subunit,Capa-2,Capa2,Capn2,Millimolar-calpain (M-calpain),m-calpain,m-calpin,mCANP

Target products collectionGo to CAPN2/Calpain 2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T04902-Ag-1/ GM-Tg-hg-T04902-Ag-2 Human CAPN2/Calpain 2 protein Human
GM-Tg-rg-T04902-Ag-1/ GM-Tg-rg-T04902-Ag-2 Rat CAPN2/Calpain 2 protein Rat
GM-Tg-mg-T04902-Ag-1/ GM-Tg-mg-T04902-Ag-2 Mouse CAPN2/Calpain 2 protein Mouse
GM-Tg-cynog-T04902-Ag-1/ GM-Tg-cynog-T04902-Ag-2 Cynomolgus/Rhesus macaque CAPN2/Calpain 2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T04902-Ag-1/ GM-Tg-felg-T04902-Ag-2 Feline CAPN2/Calpain 2 protein Feline
GM-Tg-cang-T04902-Ag-1/ GM-Tg-cang-T04902-Ag-2 Canine CAPN2/Calpain 2 protein Canine
GM-Tg-bovg-T04902-Ag-1/ GM-Tg-bovg-T04902-Ag-2 Bovine CAPN2/Calpain 2 protein Bovine
GM-Tg-equg-T04902-Ag-1/ GM-Tg-equg-T04902-Ag-2 Equine CAPN2/Calpain 2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T04902-Ag-1/ GM-Tg-hg-T04902-Ag-2; GM-Tg-rg-T04902-Ag-1/ GM-Tg-rg-T04902-Ag-2;
GM-Tg-mg-T04902-Ag-1/ GM-Tg-mg-T04902-Ag-2; GM-Tg-cynog-T04902-Ag-1/ GM-Tg-cynog-T04902-Ag-2;
GM-Tg-felg-T04902-Ag-1/ GM-Tg-felg-T04902-Ag-2; GM-Tg-cang-T04902-Ag-1/ GM-Tg-cang-T04902-Ag-2;
GM-Tg-bovg-T04902-Ag-1/ GM-Tg-bovg-T04902-Ag-2; GM-Tg-equg-T04902-Ag-1/ GM-Tg-equg-T04902-Ag-2
Products Name CAPN2/Calpain 2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CAPN2/Calpain 2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CAPN2/Calpain 2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.